The Boston Scientific spinal cord stimulator lawsuit is picking up serious momentum heading into 2026, with hundreds of patients alleging these implanted devices caused them more pain than they prevented. Plaintiffs say Boston Scientific sold defective neurostimulators that fractured, migrated, shocked patients unexpectedly, and required painful removal surgeries.
If you had a Boston Scientific spinal cord stimulator implanted and things went wrong, you’re not alone. The FDA’s own adverse event database contains thousands of reports tied to these devices.
This article breaks down every angle of the litigation: the 2026 case timeline, which models are named, estimated settlement ranges, who qualifies, and exactly how to file. By the end, you’ll know whether you have a claim and what to do about it.
One fact that might surprise you: the FDA received over 107,000 adverse event reports related to spinal cord stimulators between 2008 and 2023, making these among the most complained-about implanted devices in the country.
Boston Scientific Spinal Cord Stimulator Lawsuit
The Boston Scientific spinal cord stimulator lawsuit is a growing body of legal claims filed by patients who say the company’s SCS devices were defectively designed, poorly manufactured, or marketed without adequate warnings about serious risks.
Boston Scientific is one of the largest spinal cord stimulator makers in the world. Their SCS systems are implanted near the spinal cord to deliver electrical pulses meant to block pain signals. The idea is simple: replace pain with a mild tingling sensation.
But for many patients, the reality was far different. Instead of relief, they got lead migration, device malfunction, nerve damage, and chronic infections.
| Key Lawsuit Details | Information |
|---|---|
| Defendant | Boston Scientific Corporation |
| Type of Case | Product liability, mass tort |
| Core Allegations | Defective design, failure to warn, manufacturing defects |
| Devices Named | Precision, Precision Spectra, WaveWriter Alpha, Precision Montage |
| Number of Complaints Filed | Hundreds as of early 2026 |
| Where Cases Are Filed | Federal and state courts across the U.S. |
The lawsuits don’t just claim the devices broke down. They claim Boston Scientific knew about the problems and continued selling the products anyway.
Many plaintiffs required revision or explant surgeries. These operations are often more dangerous than the original implantation. Some patients ended up worse off than before they ever had a stimulator put in.
Boston Scientific Spinal Cord Stimulator Lawsuit 2026
The Boston Scientific spinal cord stimulator lawsuit in 2026 is entering a phase where real outcomes start to take shape. Case filings have increased, and attorneys across the country are actively reviewing new claims from patients who experienced device failures.
What makes 2026 different from prior years is the volume of evidence now available. Internal Boston Scientific documents obtained through discovery have started to reveal what the company knew about device failure rates. Several expert reports on lead fracture rates and battery malfunctions have been submitted to courts.
Attorneys expect 2026 to be a pivotal year for several reasons:
- Bellwether trial selections may begin in federal courts
- Discovery deadlines are hitting for major case groups
- State court cases in Massachusetts and Minnesota are advancing independently
- FDA enforcement actions from 2024 and 2025 are now part of the evidentiary record
The litigation landscape has shifted. Early cases were often dismissed for lack of evidence or preemption arguments. Now, with stronger evidence and more plaintiffs, the legal footing is much more solid.
If you’ve been waiting to file, 2026 is a year where delays could start to cost you. Statute of limitations deadlines vary by state, but many are tightening.
Spinal Cord Stimulator Lawsuit Update 2026
The latest spinal cord stimulator lawsuit update for 2026 shows the litigation is progressing on multiple fronts. Both federal and state courts are seeing increased activity related to Boston Scientific SCS claims.
Here’s what’s happened recently:
- Early 2026: Additional plaintiffs joined existing case groups in federal court. The total number of active cases has grown past prior year filings.
- Late 2025 into 2026: Several key expert witnesses were deposed, including biomedical engineers who tested the Precision and WaveWriter devices.
- Ongoing: Attorneys are negotiating case management orders to streamline proceedings.
| Timeline Event | Status |
|---|---|
| Initial complaints filed | Ongoing since 2020 |
| Discovery phase | Active as of 2026 |
| Expert depositions | Several completed in late 2025/early 2026 |
| Bellwether trial selection | Expected mid to late 2026 |
| Settlement talks | Preliminary stages |
| Statute of limitations | Varies by state; many expire 2 to 4 years post-injury |
The pace of these cases often feels glacial. That’s normal for medical device litigation. But behind the scenes, both sides are building their cases.
Boston Scientific has not publicly offered a global settlement. The company has denied wrongdoing in court filings. That doesn’t mean a settlement won’t happen. It just means the litigation hasn’t reached the tipping point yet.
Key Takeaway: The Boston Scientific spinal cord stimulator litigation is accelerating in 2026, with bellwether trial selections expected and discovery producing new evidence against the company.
Boston Scientific Spinal Cord Stimulator Settlement
A Boston Scientific spinal cord stimulator settlement has not been finalized as of early 2026. No global settlement agreement has been announced. But that doesn’t mean individual settlements aren’t happening behind closed doors.
In mass tort litigation, companies often settle individual cases quietly while the broader litigation continues. This is a negotiating tactic. Boston Scientific may choose to settle the most severe injury cases first to control exposure and keep verdict amounts out of the public record.
Here’s what typically drives a settlement in cases like these:
- Strength of the plaintiff’s evidence (medical records, device failure reports, surgical notes)
- Severity of the injury (nerve damage, paralysis, chronic infection, multiple revision surgeries)
- Bellwether trial outcomes (a big plaintiff verdict can push settlements quickly)
- Total number of cases filed (more cases equal more financial pressure)
Think of it like a dam. Right now, the water is building. Once the first bellwether trial produces a plaintiff verdict, the dam often breaks and settlement talks accelerate rapidly.
Patients who experienced the most severe outcomes, such as permanent nerve damage or multiple failed revision surgeries, are likely to receive the highest settlement offers. But even patients with less severe complications may have valid claims worth pursuing.
Spinal Cord Stimulator Lawsuit Settlement Amounts
Spinal cord stimulator lawsuit settlement amounts for Boston Scientific cases are projected to range from $100,000 to over $1 million depending on injury severity, according to estimates from mass tort attorneys handling these claims.
No official settlement fund exists yet. These are attorney projections based on comparable medical device cases and the severity tiers commonly used in mass tort settlements.
| Injury Tier | Estimated Settlement Range | Examples |
|---|---|---|
| Tier 1: Minor | $50,000 to $150,000 | Device removal, temporary pain increase, minor infection |
| Tier 2: Moderate | $150,000 to $500,000 | Lead migration requiring revision surgery, prolonged nerve pain |
| Tier 3: Severe | $500,000 to $1,000,000+ | Permanent nerve damage, paralysis, multiple surgeries, chronic disability |
| Tier 4: Catastrophic | $1,000,000+ | Spinal cord injury, loss of motor function, wrongful death |
These numbers come from patterns seen in other medical device mass torts, including Medtronic SCS lawsuits, St. Jude pacemaker litigation, and metal-on-metal hip implant settlements.
A few factors that increase your potential payout:
- Documented device failure through imaging or surgical records
- Multiple revision or explant surgeries
- Permanent disability or loss of employment
- Young age at time of implant (longer duration of suffering)
Your individual amount will depend on your specific situation. Two people with the same device can have very different claims based on their medical outcomes.
Who Qualifies for Spinal Cord Stimulator Lawsuit
You may qualify for a spinal cord stimulator lawsuit against Boston Scientific if you were implanted with one of their SCS devices and experienced complications that required medical treatment, additional surgery, or caused lasting harm.
Here’s a quick eligibility checklist:
- You had a Boston Scientific spinal cord stimulator implanted
- The device was a Precision, Precision Spectra, WaveWriter Alpha, or Precision Montage model
- You experienced one or more complications (lead migration, device malfunction, infection, nerve damage, unwanted shocking, battery failure)
- You required revision surgery, explant surgery, or extended medical care
- Your complications were not fully explained by your doctor before implantation
| Eligibility Factor | Qualifies? |
|---|---|
| Implanted with Boston Scientific SCS device | Yes |
| Experienced device malfunction or failure | Yes |
| Required revision or removal surgery | Yes |
| Suffered nerve damage or chronic pain worsening | Yes |
| Had a different manufacturer’s device | No (different lawsuit) |
| Had a successful implant with no issues | No |
| Family member of deceased patient | Potentially (wrongful death claim) |
You don’t need to have a “perfect” case to qualify. Even if your doctor told you the device was fine and your body was the problem, a legal review might tell a different story. Many patients were told their pain was “normal” when the device was actually malfunctioning.
Family members of patients who died from complications related to a Boston Scientific SCS device may qualify for wrongful death claims.
Key Takeaway: If you had a Boston Scientific SCS device implanted and suffered complications requiring additional medical care or surgery, you likely qualify to file a claim in 2026.
Boston Scientific Spinal Cord Stimulator Complications
Boston Scientific spinal cord stimulator complications are at the heart of every lawsuit filed against the company. These aren’t minor inconveniences. Many patients report life-altering problems that started after implantation.
The most commonly reported complications include:
- Lead migration: The thin wires (leads) shift from their original position, sending electrical pulses to the wrong area
- Lead fracture: Wires break inside the body, requiring surgical removal
- Device malfunction: The pulse generator stops working, delivers irregular stimulation, or fails entirely
- Infection: Bacterial infection at the implant site, sometimes requiring device removal
- Unwanted electrical shocks: Sudden, painful jolts that patients describe as being “tased from the inside”
- Chronic pain worsening: The device makes pain worse instead of better
- Nerve damage: Permanent injury to spinal nerves from the device or its leads
- Epidural hematoma or abscess: Dangerous fluid collections near the spinal cord
- Battery failure: Premature battery depletion requiring unplanned surgery
Some patients report multiple complications at once. A lead fracture, for example, often leads to revision surgery, which carries its own infection risk. It becomes a cascading chain of problems.
The cruel irony is that these devices are supposed to treat chronic pain. When they fail, patients end up in worse pain than they started with, plus the added trauma of repeated surgeries.
Boston Scientific Spinal Cord Stimulator Side Effects
Boston Scientific spinal cord stimulator side effects go beyond standard surgical risks. While every implant carries some risk of infection or discomfort, the side effects reported with these devices suggest deeper design and manufacturing problems.
Reported side effects include:
- Burning sensations at the implant site
- Muscle spasms triggered by electrical stimulation
- Headaches and dizziness from overstimulation
- Loss of sensation in limbs
- Difficulty walking or standing
- Sleep disruption from involuntary stimulation at night
- Skin erosion over the implant pocket
- Allergic reactions to device components
| Side Effect | Frequency in Reports | Severity |
|---|---|---|
| Unwanted shocking | Very common | Moderate to severe |
| Lead migration | Common | Severe (requires surgery) |
| Infection at implant site | Common | Moderate to severe |
| Nerve damage | Less common | Severe to permanent |
| Skin erosion | Less common | Moderate |
| Battery failure | Common | Moderate (requires surgery) |
| Chronic pain worsening | Very common | Severe |
What separates a “side effect” from a “complication” in legal terms is often about foreseeability. If Boston Scientific knew about these side effects and didn’t adequately warn patients or doctors, that’s a failure-to-warn claim. If the side effects resulted from a design flaw, that’s a defective design claim.
Many patients say they were never told about the true frequency of these side effects before consenting to the procedure. That gap in informed consent is a major legal argument in these cases.
Boston Scientific Spinal Cord Stimulator Failure Rate
The Boston Scientific spinal cord stimulator failure rate is higher than many patients were told before their procedure. Published medical literature suggests SCS failure rates across all manufacturers range from 30% to 40% within the first few years, and some studies show even higher numbers for specific device models.
A 2022 study in the journal Neuromodulation found that roughly one-third of SCS patients required device revision or removal within five years of implantation. Boston Scientific devices were among those studied.
The FDA’s MAUDE (Manufacturer and User Facility Device Experience) database tells a striking story:
- Over 107,000 adverse event reports for spinal cord stimulators were filed between 2008 and 2023
- Boston Scientific accounted for a significant percentage of those reports
- Common failure modes included lead fracture, battery depletion, and software errors
| Failure Type | Estimated Occurrence Rate |
|---|---|
| Lead migration | 13% to 23% |
| Lead fracture | 5% to 9% |
| Device infection | 3% to 8% |
| Battery failure (premature) | 5% to 10% |
| Complete device failure | 10% to 15% |
| Revision surgery required | 30% to 40% within 5 years |
Compare that to what patients are typically told before surgery. Most hear success rates around 50% to 70%. They don’t hear that “success” is often defined loosely, and they rarely hear about the high revision rates.
This gap between marketing claims and real-world performance is central to the lawsuits. Patients argue they would have chosen a different treatment if they’d known the true failure rates.
Key Takeaway: Boston Scientific SCS devices have documented failure rates far higher than what most patients were told, with up to 40% of devices requiring revision or removal within five years.
Boston Scientific Precision Spinal Cord Stimulator Problems
The Boston Scientific Precision spinal cord stimulator has been one of the most frequently cited devices in SCS lawsuits. The Precision system, including the Precision Plus and Precision Spectra models, was a flagship product for Boston Scientific’s neuromodulation division.
Problems specific to the Precision line include:
- Premature battery depletion: Patients reported batteries dying years earlier than the projected lifespan, requiring unplanned replacement surgery
- Lead migration after MRI scans: Despite being marketed as MRI-conditional, some patients experienced lead movement during or after MRI procedures
- Software glitches: The device programmer and patient remote experienced malfunctions, preventing patients from adjusting stimulation settings
- Thermal injuries: Reports of burning sensations caused by the implanted pulse generator overheating
The Precision Spectra model was marketed with a 32-contact surgical lead, which Boston Scientific promoted as offering more precise pain coverage. But the additional contacts also introduced more potential failure points.
Several FDA Class II recalls affected Precision devices:
| Recall Date | Reason | Models Affected |
|---|---|---|
| 2014 | Battery performance issues | Precision Plus |
| 2016 | Software update problems | Precision Spectra |
| 2018 | Lead connection failures | Precision Spectra |
| 2020 | Charging system defects | Precision Montage MRI |
These recalls confirm that the problems weren’t just patient complaints. The FDA found the issues serious enough to require formal corrective actions. That’s powerful evidence in a lawsuit.
Boston Scientific WaveWriter Alpha Lawsuit
The Boston Scientific WaveWriter Alpha lawsuit focuses on the company’s newer SCS platform, which was promoted as a next-generation pain relief device with dual-waveform technology. Despite being marketed as a technological leap forward, the WaveWriter Alpha has generated its own wave of complaints and legal claims.
Boston Scientific introduced the WaveWriter Alpha as a system that could deliver both paresthesia-based and sub-perception therapy simultaneously. The company touted it as a more versatile option for chronic pain patients.
But patients and their attorneys have raised serious concerns:
- Device failures within months of implantation
- Unexpected stimulation changes without patient input
- Lead issues similar to those seen with older Precision models
- Software bugs in the patient controller
- Charging difficulties with the rechargeable battery system
The WaveWriter Alpha lawsuits are particularly significant because they show the pattern didn’t stop with older devices. Boston Scientific’s next-generation product allegedly carried forward many of the same flaws.
One plaintiff in a 2025 filing alleged their WaveWriter Alpha device delivered uncontrolled high-intensity shocks during sleep, causing them to fall out of bed and fracture a hip. Another plaintiff claimed the device stopped working entirely within six months, leaving them in uncontrolled pain while waiting for removal surgery.
These cases are still relatively new, but they strengthen the argument that Boston Scientific has a systemic quality control problem across its SCS product line.
Spinal Cord Stimulator Lead Migration Lawsuit
Spinal cord stimulator lead migration is one of the most common reasons patients file lawsuits against Boston Scientific. Lead migration occurs when the thin electrode wires implanted near the spinal cord shift from their intended position.
When leads migrate, the electrical stimulation hits the wrong nerves. Instead of blocking pain, the device can create new pain, muscle spasms, or numbness in areas that were previously fine.
Think of it like a satellite dish on your roof. If it shifts even slightly, you lose signal entirely. SCS leads work the same way. A few millimeters of movement can render the device useless or harmful.
Why lead migration matters legally:
- It suggests the leads or their anchoring mechanisms are defectively designed
- It often requires invasive revision surgery, which carries additional risks
- Patients were not always warned about how frequently migration occurs
- Some patients experience multiple migrations, leading to multiple surgeries
| Lead Migration Facts | Details |
|---|---|
| Reported frequency | 13% to 23% of SCS patients |
| Most common time frame | Within first 6 months post-implant |
| Revision surgery required? | Almost always |
| Risk of nerve damage from migration | Moderate to high |
| Can it recur after revision? | Yes, frequently |
Many lead migration lawsuits allege that Boston Scientific’s lead anchoring system was inadequate. The leads were not designed to stay in place under normal body movement. Patients who exercised, bent down, or even coughed forcefully reported lead displacement.
Key Takeaway: Lead migration affects up to 23% of SCS patients and is a primary defect allegation in Boston Scientific lawsuits, often requiring dangerous revision surgery.
Boston Scientific Spinal Cord Stimulator Recall
Boston Scientific has issued multiple recalls for its spinal cord stimulator products over the years. These recalls, classified by the FDA as Class I (most serious) and Class II events, provide strong evidence for plaintiffs in the ongoing litigation.
A device recall doesn’t necessarily mean every device is pulled from patients. In many cases, the “recall” involves a safety alert, software update, or instructions for physicians to monitor specific patients. But the existence of a recall confirms that the FDA found a problem serious enough to require action.
Key Boston Scientific SCS recalls include:
| Year | Device | Issue | FDA Class |
|---|---|---|---|
| 2014 | Precision Plus | Battery performance deficiency | Class II |
| 2016 | Precision Spectra | Software malfunction | Class II |
| 2018 | Precision Spectra | Lead connector failure | Class II |
| 2020 | Precision Montage MRI | Charging system defect | Class II |
| 2022 | WaveWriter Alpha | IPG communication errors | Class II |
| 2024 | Multiple SCS models | Thermal risk during certain procedures | Class II |
For lawsuits, recalls serve two purposes. First, they show the device had a known defect. Second, they can prove that Boston Scientific was aware of the problem, which supports failure-to-warn and negligence claims.
If your device was subject to a recall, that’s a significant piece of evidence for your case. Even if the recall occurred after your injury, it demonstrates a pattern of defects in the product line.
Spinal Cord Stimulator MDL Status 2026
The spinal cord stimulator MDL status in 2026 is a key factor for anyone following these cases. MDL stands for Multidistrict Litigation, a legal process where similar federal cases are grouped together before one judge for pre-trial proceedings.
As of early 2026, attorneys have been pushing for formal MDL consolidation of Boston Scientific SCS cases. The Judicial Panel on Multidistrict Litigation (JPML) evaluates whether enough cases with common questions of fact exist to warrant consolidation.
What MDL consolidation means for plaintiffs:
- All federal Boston Scientific SCS cases would be transferred to one court
- A single judge would oversee discovery, depositions, and pre-trial motions
- Bellwether (test) trials would be selected to gauge how juries might respond
- The process is more efficient than hundreds of individual trials
- A successful bellwether verdict can trigger global settlement talks
| MDL Process Stage | Current Status (2026) |
|---|---|
| Filing threshold (enough cases) | Met |
| JPML petition filed | Under review / pending |
| Consolidation decision | Expected mid-2026 |
| Assigned judge | TBD |
| Bellwether trial selection | Expected late 2026 to early 2027 |
| Global settlement potential | Post-bellwether |
MDL is not a class action. Each plaintiff maintains their individual case. The MDL simply streamlines the pre-trial work so every plaintiff doesn’t have to reinvent the wheel.
If consolidation is granted, it will significantly speed up the litigation. It will bring organized pressure on Boston Scientific to negotiate.
How to File a Spinal Cord Stimulator Lawsuit
Filing a spinal cord stimulator lawsuit against Boston Scientific involves several steps, but the process is simpler than most people expect. You don’t need to do it alone, and most attorneys handling these cases work on a contingency fee basis, meaning you pay nothing upfront.
Step-by-step process:
- Gather your medical records. This includes surgical reports from your SCS implant, any revision or removal procedures, imaging studies, and your device identification card.
- Contact a mass tort or product liability attorney. Look for a firm with specific experience in medical device litigation. They will review your case for free during an initial consultation.
- Your attorney investigates. They’ll obtain your device records from Boston Scientific, review FDA adverse event reports, and collect expert opinions.
- File the complaint. Your attorney prepares and files the legal complaint in the appropriate court, either federal or state.
- Join the litigation. If an MDL exists, your case may be transferred there. If not, it proceeds individually or as part of a state-level group.
| Filing Checklist Item | Why It Matters |
|---|---|
| Device model and serial number | Identifies the specific product in your claim |
| Surgical and medical records | Proves what happened to you |
| Timeline of complications | Establishes when problems began |
| Photos of scars or injuries | Visual evidence of harm |
| Employment and income records | Supports lost wages claims |
| Prescription history | Shows pain management needs post-complication |
Statute of limitations warning: Every state has a deadline for filing medical device lawsuits. Most states allow 2 to 4 years from the date of injury or date of discovery. Waiting too long can permanently bar your claim.
Key Takeaway: Filing a Boston Scientific SCS lawsuit requires gathering medical records, consulting a product liability attorney, and acting before your state’s filing deadline expires.
Spinal Cord Stimulator Class Action Lawsuit
A spinal cord stimulator class action lawsuit is not the same as the mass tort litigation currently underway against Boston Scientific. This distinction matters because it affects how your case is handled and what you might receive.
Class action vs. mass tort:
| Feature | Class Action | Mass Tort |
|---|---|---|
| Individual case evaluation | No; everyone gets the same result | Yes; each case valued separately |
| Customized compensation | No | Yes, based on your specific injuries |
| Control over your case | Minimal | More control |
| Attorney relationship | Shared among all class members | Direct relationship with your lawyer |
| Typical in medical device cases | Rare | Very common |
The Boston Scientific SCS litigation is structured as a mass tort, not a class action. This is actually better for most plaintiffs. In a class action, everyone gets the same payout regardless of how badly they were hurt. In a mass tort, your case is evaluated individually.
If you suffered permanent nerve damage and needed four surgeries, you’ll be compensated differently than someone who had minor complications and one revision. That’s the advantage of mass tort structure.
However, the term “class action” is commonly used by the general public when searching for these lawsuits. If you’ve been searching for a “spinal cord stimulator class action,” you’re looking in the right place. The legal structure is just called something different.
Your attorney can explain how your individual case fits into the broader litigation. The key point is that your injuries and your experience matter individually. You’re not just a number in a group.
Frequently Asked Questions
How much compensation can I get from a Boston Scientific spinal cord stimulator lawsuit?
Settlement estimates range from $50,000 to over $1 million depending on injury severity.
Factors like number of surgeries, permanent nerve damage, and lost income determine your payout.
No global settlement has been announced yet, so final amounts are still being determined.
What is the deadline to file a Boston Scientific spinal cord stimulator claim in 2026?
Deadlines depend on your state’s statute of limitations, which typically runs 2 to 4 years from the date of injury or discovery.
Some states apply a “discovery rule,” meaning your clock starts when you learned the device caused your harm.
Consulting an attorney as soon as possible is the best way to protect your right to file.
Which Boston Scientific spinal cord stimulator models are included in the lawsuit?
The Precision Plus, Precision Spectra, WaveWriter Alpha, and Precision Montage MRI are the primary models named in litigation.
Other Boston Scientific SCS products may qualify depending on the specific defect involved.
An attorney can verify whether your device is covered.
Can I still file a lawsuit if my spinal cord stimulator was removed?
Yes, you can file a claim even if your device has already been removed.
In fact, requiring removal surgery strengthens your case by proving the device failed.
Keep all surgical and pathology records related to the explant procedure.
Is the Boston Scientific spinal cord stimulator lawsuit a class action or mass tort?
It is a mass tort, not a class action.
In a mass tort, each plaintiff’s case is evaluated individually based on their specific injuries.
This structure typically results in higher compensation for severely injured plaintiffs.
The Boston Scientific spinal cord stimulator lawsuit is real, it’s growing, and 2026 is shaping up to be a year of major developments. If you experienced complications from one of these devices, your window to take action may be narrowing.
Gather your medical records. Talk to a product liability attorney who handles medical device cases. Don’t wait for a class action notice that may never come. Your claim is individual, and it deserves individual attention.
The evidence is building. The question is whether you’ll be part of it.
